RESUMEN
In 2006, a new virus, xenotropic murine leukemia virus-related virus (XMRV), was discovered in a cohort of U.S. men with prostate cancer. Soon after this initial finding, XMRV was also detected in samples from patients with chronic fatigue syndrome (CFS). The blood community, which is highly sensitive to the threat of emerging infectious diseases since the HIV/AIDS crisis, recommended indefinite deferral of all blood donors with a history of CFS. As XMRV research progressed, conflicting results emerged regarding the importance of this virus in the pathophysiology of prostate cancer and/or CFS. Molecular biologists traced the development of XMRV to a recombination event in a laboratory mouse that likely occurred circa 1993. The virus was propagated via cell lines derived from a tumor present in this mouse and spread through contamination of laboratory samples. Well-controlled experiments showed that detection of XMRV was due to contaminated samples and was not a marker of or a causal factor in prostate cancer or CFS. This paper traces the development of XMRV in the prostate and CFS scientific communities and explores the effect it had on the blood community.
Asunto(s)
Síndrome de Fatiga Crónica/etiología , Neoplasias de la Próstata/etiología , Infecciones por Retroviridae/complicaciones , Infecciones por Retroviridae/transmisión , Reacción a la Transfusión , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Animales , Sangre/virología , Evolución Molecular , Síndrome de Fatiga Crónica/epidemiología , Humanos , Masculino , Ratones , Neoplasias de la Próstata/epidemiología , Infecciones por Retroviridae/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genéticaRESUMEN
Protein A chromatography is the most common unit operation used in the manufacture of therapeutic monoclonal antibodies (mAbs) due to its high affinity and specificity for the IgG Fc domain. However, protein A chromatography is often not effective for viral clearance. Typical log reduction values (LRV) for the model retrovirus XMuLV range between 1 and 4 logs, while effective steps such as viral filtration can achieve 5-7 logs of clearance. XMuLV LRVs obtained on protein A are reproducible for a given mAb, but can vary widely for different mAbs, even with the same operating conditions. In order to understand the mechanism of XMuLV clearance on protein A, we have investigated its partitioning on Mabselect SuRe protein A resin and explored how the virus interacts with resin, product, and impurities. The results show that XMuLV has some interaction with the resin backbone and ligand, but also appears to bind to and coelute with the mAb. The interaction with product was further examined by evaluating the effect of feed conditions, loading, and different washes on XMuLV partitioning on the column. Understanding the mechanism of XMuLV removal on a protein A, resin provides insight into the variability and low viral clearance of this step and suggests ways in which the removal of virus by this step can be improved.
Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Cromatografía de Afinidad/métodos , Proteína Estafilocócica A/metabolismo , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Medios de Cultivo/químicaRESUMEN
The discovery of xenotropic murine leukemia virus-related virus (XMRV) in human tissue samples has been shown to be due to virus contamination with a recombinant murine retrovirus. However, due to the unknown pathogenicity of this novel retrovirus and its broad host range, including human cell lines, it is important to understand the modes of virus transmission and develop mitigation and management strategies to reduce the risk of human exposure and infection. XMRV transmission was evaluated by whole-blood transfusion in rhesus macaques. Monkeys were infected with XMRV to serve as donor monkeys for blood transfers at weeks 1, 2, and 3 into naïve animals. The donor and recipient monkeys were evaluated for XMRV infection by nested PCR assays with nucleotide sequence confirmation, Western blot assays for development of virus-specific antibodies, and coculture of monkey peripheral blood mononuclear cells (PBMCs) with a sensitive target cell line for virus isolation. XMRV infection was demonstrated in the virus-injected donor monkeys, but there was no evidence of virus transmission by whole-blood transfusion to naïve monkeys based upon PCR analysis of PBMCs using XMRV-specific gag and env primers, Western blot analysis of monkey plasma up to 31 to 32 weeks after transfusion, and coculture studies using monkey PBMCs from various times after transfusion. The study demonstrates the lack of XMRV transmission by whole-blood transfusion during the acute phase of infection. Furthermore, analysis of PBMC viral DNA showed extensive APOBEC-mediated G-to-A hypermutation in a donor animal at week 9, corroborating previous results using macaques and supporting the possible restriction of XMRV replication in humans by a similar mechanism.
Asunto(s)
Macaca mulatta , Infecciones por Retroviridae/transmisión , Reacción a la Transfusión , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Animales , Anticuerpos Antivirales/sangre , Western Blotting , Células Cultivadas , Técnicas de Cocultivo , ADN Viral/genética , ADN Viral/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genéticaRESUMEN
Although xenotropic murine leukemia virus-related virus (XMRV) has been regarded as a laboratory contaminant, it remains one of the most controversial viruses. The objective of the study was to determine if XMRV is present in 44 patients with beta-thalassemia major, 48 with sickle cell disease, and 89 volunteer blood donors. After RNA/ DNA extraction from plasma/buffy coat the samples were screened for XMRV sequences by conserved nested GAG primers. None of the RNA samples showed a positive result. Surprisingly, four DNA samples obtained from blood donors were positive for XMRV provirus. The subsequent phylogenetic analysis revealed that these sequences are identical to the positive control (murine leukemia retrovirus) and are probably consistent with laboratory contamination. XMRV infection (provirus and viral RNA) was absent in multiply transfused patients and volunteer blood donors. The positive result obtained from some blood donors probably reflects laboratory contamination. We believe that XMRV does not pose risk to blood transfusion.
Asunto(s)
Anemia de Células Falciformes/virología , Infecciones por Retroviridae/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Talasemia beta/virología , Adolescente , Adulto , Animales , Donantes de Sangre , Transfusión Sanguínea , Brasil , Niño , Preescolar , Femenino , Humanos , Masculino , Ratones , Persona de Mediana Edad , Datos de Secuencia Molecular , Filogenia , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/clasificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Adulto JovenRESUMEN
Xenotropic murine leukemia virus-related virus (XMRV) has been considered a possible trigger of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) and could also be linked with unspecified encephalopathy. The aim of this study was to analyse the frequency of XMRV proviral sequences in peripheral blood leukocyte (PBL) DNA from 150 patients with ME/CFS and 30 apparently healthy individuals, as well as in PBL and brain tissue DNA from 61 individuals with/without unspecified encephalopathy. Targeting the XMRV proviral gag gene sequence by nested polymerase chain reaction (nPCR) with previously reported primer sets, provirus was not detected either in DNA from patients with ME/CFS and individuals with unspecified encephalopathy, or in apparently healthy individuals. Only the positive control gave the amplimer of 410 base pairs (bp) after the second round that corresponds to the expected XMRV gag gene fragment. In addition, DNA was found to be negative in nPCR assays, targeting XMRV specific env gene sequence, using previously described primer sets. Also only positive control gave the amplimer of 218 bp after the second round, corresponding to the expected XMRV env gene fragment. Using nPCR we found no evidence of XMRV infection either in apparently healthy individuals or in patients with ME/CFS and individuals with unspecified encephalopathy.
Asunto(s)
Encefalopatías/etiología , Síndrome de Fatiga Crónica/etiología , Provirus/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adulto , Encefalopatías/virología , Cartilla de ADN/genética , Síndrome de Fatiga Crónica/virología , Femenino , Productos del Gen gag/genética , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Provirus/genética , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genéticaRESUMEN
Xenotropic murine leukemia virus-related virus (XMRV) was previously reported to be associated with human prostate cancer and chronic fatigue syndrome. Our groups recently showed that XMRV was created through recombination between two endogenous murine retroviruses, PreXMRV-1 and PreXMRV-2, during the passaging of a prostate tumor xenograft in nude mice. Here, multiple approaches that led to the identification of PreXMRV-2, as well as the distribution of both parental proviruses among different mouse species, are described. The chromosomal loci of both proviruses were determined in the mouse genome, and integration site information was used to analyze the distribution of both proviruses in 48 laboratory mouse strains and 46 wild-derived strains. The strain distributions of PreXMRV-1 and PreXMRV-2 are quite different, the former being found predominantly in Asian mice and the latter in European mice, making it unlikely that the two XMRV ancestors could have recombined independently in the wild to generate an infectious virus. XMRV was not present in any of the mouse strains tested, and among the wild-derived mouse strains analyzed, not a single mouse carried both parental proviruses. Interestingly, PreXMRV-1 and PreXMRV-2 were found together in three laboratory strains, Hsd nude, NU/NU, and C57BR/cd, consistent with previous data that the recombination event that led to the generation of XMRV could have occurred only in the laboratory. The three laboratory strains carried the Xpr1(n) receptor variant nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that the xenografted human tumor cells were required for the resulting XMRV recombinant to infect and propagate.
Asunto(s)
Ratones/virología , Provirus/genética , Infecciones por Retroviridae/veterinaria , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Mapeo Cromosómico , Femenino , Humanos , Masculino , Ratones/genética , Ratones Endogámicos , Datos de Secuencia Molecular , Provirus/aislamiento & purificación , Provirus/fisiología , Ratas , Ratas Sprague-Dawley , Receptores Virales/química , Receptores Virales/genética , Recombinación Genética , Infecciones por Retroviridae/virología , Alineación de Secuencia , Integración Viral , Receptor de Retrovirus Xenotrópico y Politrópico , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/fisiologíaRESUMEN
BACKGROUND: Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus reported to be associated with prostate cancer (PC) and chronic fatigue syndrome (CFS). While the association of XMRV with CFS and PC has recently been discredited, no studies have been performed in Australian patients to investigate the association between PC and XMRV or related murine leukemia virus (MLV) in matched PC and normal tissue. METHODS: Genomic DNA (gDNA) was purified from matched normal and cancer formalin-fixed paraffin-embedded (FFPE) prostate tissue from 35 Australian PC patients with Gleason scores ranging from 7 - 10. The presence of the ribonuclease L (RNase L) polymorphism R462Q was determined by allele specific PCR. Samples were screened for XMRV and related murine leukemia virus (MLV) variants by qPCR. Contaminating mouse DNA was detected using qPCR targeting mouse intracisternal A particle long terminal repeat DNA. RESULTS: gDNA was successfully purified from 94% (66/70) of normal and cancer FFPE prostate tissues. RNase L typing revealed 8% were homozygous (QQ), 60% were heterozygous (RQ) and 32% were wild-type (RR) for the RNase L mutation. None of the 66 samples tested were positive for XMRV or related MLV sequences using broad MLV or XMRV specific primers with detection sensitivities of 1 viral copy of MLV/XMRV and XMRV DNA, respectively. CONCLUSIONS: Using highly sensitive qPCR we found no evidence of XMRV or related gammaretroviruses in prostate tissues from 35 Australian PC patients. Our findings are consistent with other studies demonstrating that XMRV is a laboratory contaminant that has no role in the aetiology of PC.
Asunto(s)
Neoplasias de la Próstata/etiología , Neoplasias de la Próstata/virología , Infecciones por Retroviridae/complicaciones , Infecciones por Retroviridae/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/patogenicidad , Anciano , Australia , Estudios de Casos y Controles , Humanos , Masculino , Persona de Mediana Edad , Próstata/virología , Reacción en Cadena en Tiempo Real de la PolimerasaRESUMEN
High throughput screening (HTS) of chromatography resins can accelerate downstream process development by rapidly providing information on product and impurity partitioning over a wide range of experimental conditions. In addition to the removal of typical product and process-related impurities, chromatography steps are also used to remove potential adventitious viral contaminants and non-infectious retrovirus-like particles expressed by rodent cell lines used for production. This article evaluates the feasibility of using HTS in a 96-well batch-binding format to study removal of the model retrovirus xenotropic murine leukemia virus (xMuLV) from product streams. Two resins were examined: the anion exchange resin Q Sepharose Fast Flow™ (QSFF) and Capto adhere™, a mixed mode resin. QSFF batch-binding HTS data was generated using two mAbs at various pHs, NaCl concentrations, and levels of impurities. Comparison of HTS data to that generated using the column format showed good agreement with respect to virus retentation at different pHs, NaCl concentrations and impurity levels. Results indicate that NaCl concentration and impurity level, but not pH, are key parameters that can impact xMuLV binding to both resins. Binding of xMuLV to Capto adhere appeared to tolerate higher levels of NaCl and impurity than QSFF, and showed some product-specific impact on binding that was not observed with QSFF. Overall, the results demonstrate that the 96-well batch-binding HTS technique can be an effective tool for rapidly defining conditions for robust virus clearance on chromatographic resins.
Asunto(s)
Biotecnología/métodos , Cromatografía/métodos , Ensayos Analíticos de Alto Rendimiento/métodos , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Animales , Células CHO , Cricetulus , Concentración de Iones de Hidrógeno , SalinidadRESUMEN
In 2006, a new retrovirus was isolated from prostate cancer patient tissue. Named xenotropic murine leukemia virus-related virus (XMRV), this was potentially the third class of retrovirus to be pathogenic in humans. XMRV made a more dramatic impact on the wider scientific community, and indeed the media, in 2009 when it was reported to be present in a remarkably high proportion of patients with chronic fatigue syndrome as well as a significant, albeit smaller, proportion of healthy controls. The apparent strong link to disease and the fear of a previously unknown retrovirus circulating in the general population lead to a surge in XMRV research. Subsequent studies failed to find an association of XMRV with disease and, in most cases, failed to find the virus in human samples. In 2011, the case against XMRV and human disease strengthened, ending with several decisive publications revealing the origin of the virus and demonstrating contamination of samples. In this review, we outline the passage of research on XMRV and its potential association with disease from its isolation to the present day, where we find ourselves at the end of a turbulent story.
Asunto(s)
Síndrome de Fatiga Crónica/virología , Neoplasias de la Próstata/virología , Virología/historia , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/patogenicidad , Historia del Siglo XXI , Humanos , MasculinoRESUMEN
Chronic fatigue syndrome (CFS) is a multisystem disorder characterized by prolonged and severe fatigue that is not relieved by rest. Attempts to treat CFS have been largely ineffective primarily because the etiology of the disorder is unknown. Recently, CFS has been associated with xenotropic murine leukemia virus-related virus (XMRV) as well as other murine leukemia virus (MLV)-related viruses, though not all studies have found these associations. We collected blood samples from 100 CFS patients and 200 self-reported healthy volunteers from the same geographical area. We analyzed these in a blind manner using molecular, serological, and viral replication assays. We also analyzed samples from patients in the original study that reported XMRV in CFS patients. We did not find XMRV or related MLVs either as viral sequences or infectious viruses, nor did we find antibodies to these viruses in any of the patient samples, including those from the original study. We show that at least some of the discrepancy with previous studies is due to the presence of trace amounts of mouse DNA in the Taq polymerase enzymes used in these previous studies. Our findings do not support an association between CFS and MLV-related viruses, including XMRV, and the off-label use of antiretrovirals for the treatment of CFS does not seem justified at present.
Asunto(s)
Síndrome de Fatiga Crónica/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adulto , Secuencia de Bases , Western Blotting , Cartilla de ADN , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Reacción en Cadena de la Polimerasa , Replicación Viral , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/fisiologíaRESUMEN
We analyzed xenotropic murine leukemia virus-related virus (XMRV) integration site sequences previously identified from human prostate tissues for single-nucleotide polymorphisms (SNPs) to discriminate between patient and potential cell line sources of the proviruses. The SNPs of two integration sites were identical to those in cell lines but not the patients, whereas the data on the remaining 12 integration sites were inconclusive. Our results provide direct evidence for contamination during analysis of XMRV integration sites.
Asunto(s)
Polimorfismo de Nucleótido Simple/genética , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/virología , Infecciones por Retroviridae/virología , Integración Viral/genética , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Animales , Secuencia de Bases , Humanos , Masculino , Ratones , Datos de Secuencia Molecular , Provirus/genética , Infecciones por Retroviridae/genética , Homología de Secuencia de Ácido Nucleico , Células Tumorales Cultivadas , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/patogenicidadRESUMEN
Recent reports showed many patients with chronic fatigue syndrome (CFS) harbor a retrovirus, xenotropic murine leukemia-related virus (XMRV), in blood; other studies could not replicate this finding. A useful next step would be to examine cerebrospinal fluid, because in some patients CFS is thought to be a brain disorder. Finding a microbe in the central nervous system would have greater significance than in blood because of the integrity of the blood-brain barrier. We examined cerebrospinal fluid from 43 CFS patients using polymerase chain reaction techniques, but did not find XMRV or multiple other common viruses, suggesting that exploration of other causes or pathogenetic mechanisms is warranted.
Asunto(s)
Infecciones del Sistema Nervioso Central/virología , Síndrome de Fatiga Crónica/virología , Virus/aislamiento & purificación , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adulto , Animales , Infecciones del Sistema Nervioso Central/diagnóstico , Líquido Cefalorraquídeo/virología , Técnicas de Cocultivo , Cartilla de ADN , ADN Viral/líquido cefalorraquídeo , Síndrome de Fatiga Crónica/líquido cefalorraquídeo , Femenino , Humanos , Masculino , Ratones , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Espectrometría de Masa por Ionización de Electrospray , Virus/genética , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genéticaRESUMEN
BACKGROUND: Xenotropic murine leukemia virus-related virus (XMRV) is a novel human gammaretrovirus that was first identified in patients with prostate cancer in 2006. Subsequent studies have shown that XMRV is also detected in patients with chronic fatigue syndrome (CFS) and even in some healthy controls and blood donors. However, some conflicting findings have been reported by different laboratories or in different regions. The association of XMRV with human diseases and the prevalence of XMRV in different populations needs to be further determined. STUDY DESIGN AND METHODS: XMRV was screened in 391 blood samples from healthy blood donors in China. Nested reverse transcription-polymerase chain reaction (PCR) was used to amplify gag and env genes of XMRV from total RNA of peripheral blood mononuclear cells (PBMNCs) and plasma, respectively. Quantitative PCR was performed to detect XMRV env gene in genomic DNA of PBMNCs. To enhance the detection sensitivity, plasma was added into LNCaP cells to amplify XMRV in the plasma samples. RESULTS: No XMRV was found in the 391 blood donors in China or in the LNCaP cells inoculated with plasma from the blood donors. CONCLUSION: Both PCR and virus isolation in highly permissive LNCaP cells failed to detect XMRV in 391 Chinese blood donors, indicating that XMRV infection might not be present in blood donors in China.
Asunto(s)
Donantes de Sangre/estadística & datos numéricos , Infecciones por Retroviridae/epidemiología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adolescente , Adulto , Animales , Seguridad de la Sangre , Línea Celular Tumoral , China/epidemiología , Síndrome de Fatiga Crónica/epidemiología , Síndrome de Fatiga Crónica/virología , Humanos , Masculino , Ratones , Células 3T3 NIH , ARN Viral/genética , ARN Viral/aislamiento & purificación , Infecciones por Retroviridae/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Adulto JovenRESUMEN
BACKGROUND: Xenotropic murine leukemia virus (MLV)-related virus (XMRV) and other related MLVs have been described with chronic fatigue syndrome and certain types of prostate cancer. In addition, prevalence rates as high as 7% have been reported in blood donors, raising the risk of transfusion-related transmission. Several laboratories have utilized microneutralization assays as a surrogate marker for detection of anti-MLV serologic responses--with up to 25% of prostate cancer patients reported to harbor neutralizing antibody responses. STUDY DESIGN AND METHODS: We developed a high-throughput microneutralization assay for research studies on blood donors using retroviral vectors pseudotyped with XMRV-specific envelopes. Infection with these pseudotypes was neutralized by sera from both macaques and mice challenged with XMRV, but not preimmune serum. A total of 354 plasma samples from blood donors in the Reno/Tahoe area were screened for neutralization. RESULTS: A total of 6.5% of donor samples gave moderate neutralization of XMRV, but not control pseudotypes. However, further testing by Western blot revealed no evidence of antibodies against MLVs in any of these samples. Furthermore, no evidence of infectious virus or viral nucleic acid was observed. CONCLUSION: A microneutralization assay was developed for detection of XMRV and can be applied in a high-throughput format for large-scale studies. Although a proportion of blood donors demonstrated the ability to block XMRV envelope-mediated infection, we found no evidence that this inhibition was mediated by specific antibodies elicited by exposure to XMRV or MLV. It is likely that this moderate neutralization is mediated through another, nonspecific mechanism.
Asunto(s)
Donantes de Sangre , Ensayos Analíticos de Alto Rendimiento/métodos , Virus de la Leucemia Murina/aislamiento & purificación , Pruebas de Neutralización/métodos , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Animales , Anticuerpos Neutralizantes , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/aislamiento & purificación , Donantes de Sangre/estadística & datos numéricos , Línea Celular Tumoral , Femenino , Células HEK293 , Humanos , Virus de la Leucemia Murina/inmunología , Macaca mulatta , Masculino , Ratones , Microquímica/métodos , Células 3T3 NIH , Infecciones por Retroviridae/sangre , Infecciones por Retroviridae/diagnóstico , Infecciones por Retroviridae/epidemiología , Infecciones por Retroviridae/virología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/inmunologíaRESUMEN
BACKGROUND: Xenotropic murine leukemia virus-related virus (XMRV) has been reported in patients with prostate cancer and chronic fatigue syndrome. Although results have been conflicting, the potential of XMRV as an infectious human retrovirus has raised concerns about transfusion safety. To address this issue, normal and retrovirus-infected blood donors were screened for evidence of XMRV infection. STUDY DESIGN AND METHODS: Plasma from 1000 US, 100 human immunodeficiency virus Type 1-infected Cameroonian, and 642 human T-lymphotropic virus Type I (HTLV-I)-infected or uninfected Japanese blood donors as well as 311 sexually transmitted disease diagnostic specimens were screened for antibodies to XMRV gp70 and p15E using chemiluminescent immunoassays (CMIAs). CMIA-reactive samples were evaluated by p30 CMIA, Western blot, and real-time reverse transcriptase polymerase chain reaction. RESULTS: XMRV seroreactivity was low (0%-0.6%) with the exception of the HTLV-I-infected donors (4.9%). Antibody was detected against only a single XMRV protein (p15E or gp70); none of the seroreactive samples had detectable XMRV pol or env sequences. The elevated seroreactivity in HTLV-I-infected donors was due to an increased p15E seroreactive rate (4.1%). Inspection of XMRV and HTLV sequences revealed a high level of conservation within the immunodominant region (IDR) of the transmembrane protein. In some cases, HTLV IDR peptide competitively reduced the XMRV p15E signal. CONCLUSIONS: Based on the low prevalence of seroreactivity, detection of antibody to only a single XMRV protein and the absence of XMRV sequences, this study finds no compelling evidence of XMRV in normal or retrovirus-infected blood donors. The increased p15E seroreactivity observed in HTLV infection is likely due to cross-reactive antibodies.
Asunto(s)
Donantes de Sangre/estadística & datos numéricos , Infecciones por Retroviridae/sangre , Infecciones por Retroviridae/epidemiología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Anticuerpos/sangre , Seguridad de la Sangre , Síndrome de Fatiga Crónica/sangre , Síndrome de Fatiga Crónica/epidemiología , Síndrome de Fatiga Crónica/virología , Salud , Humanos , Población , ARN Viral/análisis , ARN Viral/aislamiento & purificación , Infecciones por Retroviridae/transmisión , Infecciones por Retroviridae/virología , Proteínas Oncogénicas de Retroviridae/análisis , Proteínas Oncogénicas de Retroviridae/genética , Proteínas Oncogénicas de Retroviridae/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Riesgo , Estudios Seroepidemiológicos , Enfermedades Virales de Transmisión Sexual/sangre , Enfermedades Virales de Transmisión Sexual/epidemiología , Enfermedades Virales de Transmisión Sexual/virología , Proteínas del Envoltorio Viral/análisis , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/inmunología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/inmunologíaRESUMEN
BACKGROUND: When xenotropic murine leukemia virus-related virus (XMRV) was first reported in association with chronic fatigue syndrome, it was suggested that it might offer a risk to blood safety. Thus, the prevalence of the virus among blood donors and, if present, its transmissibility by transfusion need to be defined. STUDY DESIGN AND METHODS: Two populations of routine blood donor samples (1435 and 13,399) were obtained for prevalence evaluations; samples from a linked donor-recipient repository were also evaluated. Samples were tested for the presence of antibodies to XMRV-related recombinant antigens and/or for XMRV RNA, using validated, high-throughput systems. RESULTS: The presence of antibodies to XMRV could not be confirmed among a total of 17,249 blood donors or recipients (0%; 95% confidence interval [CI], 0%-0.017%); 1763 tested samples were nonreactive for XMRV RNA (0%; 95% CI, 0%-0.17%). Evidence of infection was absent from 109 recipients and 830 evaluable blood samples tested after transfusion of a total of 3741 blood components. CONCLUSIONS: XMRV and related murine leukemia virus (MLV) markers are not present among a large population of blood donors and evidence of transfusion transmission could not be detected. Thus, these viruses do not currently pose a threat to blood recipient safety and further actions relating to XMRV and MLV are not justified.
Asunto(s)
Seguridad de la Sangre , Infecciones por Retroviridae/sangre , Infecciones por Retroviridae/transmisión , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/fisiología , Adolescente , Adulto , Donantes de Sangre/estadística & datos numéricos , Seguridad de la Sangre/métodos , Recolección de Muestras de Sangre/métodos , Recolección de Muestras de Sangre/normas , Recolección de Muestras de Sangre/estadística & datos numéricos , Síndrome de Fatiga Crónica/sangre , Síndrome de Fatiga Crónica/epidemiología , Síndrome de Fatiga Crónica/etiología , Síndrome de Fatiga Crónica/virología , Femenino , Humanos , Masculino , Persona de Mediana Edad , ARN Viral/sangre , ARN Viral/aislamiento & purificación , Infecciones por Retroviridae/epidemiología , Infecciones por Retroviridae/virología , Factores de Riesgo , Pruebas Serológicas , Trasplante/fisiología , Trasplante/estadística & datos numéricos , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/genética , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificaciónRESUMEN
Prostate cancer is one of the most prevalent types of cancer in men. Controversial data exist concerning the role of BKPyV and the xenotropic murine leukaemia virus-related gammaretrovirus (XMRV) in prostate cancer development. We therefore assessed the association between prostate cancer and viral infections. We could detect BKPyV in only 1 out of 85 prostate cancer samples, whereas none of the tissue samples showed evidence for XMRV positivity. Lack of detection of BKPyV and XMRV in prostate cancer tissues suggests that these viruses do not play a role in the pathogenesis of this type of cancer.
Asunto(s)
Virus BK/aislamiento & purificación , Infecciones por Polyomavirus/epidemiología , Neoplasias de la Próstata/epidemiología , Neoplasias de la Próstata/etiología , Infecciones por Retroviridae/epidemiología , Infecciones Tumorales por Virus/epidemiología , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adulto , Anciano , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Polyomavirus/virología , Prevalencia , Neoplasias de la Próstata/virología , Infecciones por Retroviridae/virología , Infecciones Tumorales por Virus/virologíaRESUMEN
BACKGROUND: Xenotropic murine leukaemia virus-related virus (XMRV) has been detected in patients with prostate cancer and chronic fatigue syndrome (CFS). The detection of XMRV in healthy individuals has raised concern about a possible virus transmission by blood products. However, recent studies challenge the association between XMRV and human disease. This study investigated whether or not XMRV is present in patients with altered immune function and individuals at increased risk of blood-borne viral infections in Germany. METHODS: We investigated 503 peripheral blood mononuclear cell (PBMC) samples from 240 patients with iatrogenic immune suppression (71 haematopoietic stem cell recipients, 132 solid organ transplant recipients, 37 others) and 311 PBMC samples from 302 patients with HIV-1 infection for the presence of proviral XMRV by real-time polymerase chain reaction (PCR). RESULTS: All 814 PBMC samples from 542 patients tested negative for XMRV DNA and positive for an internal herpesvirus saimiri (HVS) control. Human genomic DNA was detected in all samples, and 90% of the samples contained >10,000 cell equivalents per XMRV PCR reaction. CONCLUSIONS: Our failure to detect proviral XMRV provides evidence against the presence of XMRV in patients at increased risk of viral infections in Germany.
Asunto(s)
Huésped Inmunocomprometido , Leucocitos Mononucleares/virología , Infecciones por Retroviridae/sangre , Virus Relacionado con el Virus Xenotrópico de la Leucemia Murina/aislamiento & purificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Antivirales/sangre , Niño , Preescolar , ADN Viral/análisis , Femenino , Infecciones por VIH/sangre , Humanos , Terapia de Inmunosupresión , Lactante , Masculino , Persona de Mediana Edad , Trasplante de Órganos , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Adulto JovenRESUMEN
The xenotropic murine leukemia virus-related virus (XMRV) has been recently linked to chronic fatigue syndrome in a US cohort in whom the virus was demonstrated in 67% patients vs 3.7% healthy controls. Albeit this finding was not substantiated by subsequent reports and eventually considered a laboratory contamination, the matter is still the object of intense debate and scrutiny in various cohorts of patients. In this work we examined well-clinically characterized Italian patients affected by chronic fatigue syndrome, and also fibromyalgia and rheumatoid arthritis, two chronic illnesses of basically unknown etiology which show quite a few symptoms in common with chronic fatigue syndrome. Although we used recently updated procedures and controls, the XMRV was not found in 65 patients with chronic fatigue syndrome diagnosis, 55 with fibromyalgia, 25 with rheumatoid arthritis, nor in 25 healthy controls. These results add to the ever-growing number of surveys reporting the absence of XMRV in chronic fatigue syndrome patients and suggest that the virus is also absent in fibromyalgia and rheumatoid arthritis.